Cite
Efficacy of Helicobacter pylori eradication for the 1(st) line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
MLA
Kim, Hawk, et al. “Efficacy of Helicobacter Pylori Eradication for the 1(St) Line Treatment of Immune Thrombocytopenia Patients with Moderate Thrombocytopenia.” Annals of Hematology, vol. 94, no. 5, May 2015, pp. 739–46. EBSCOhost, https://doi.org/10.1007/s00277-014-2268-9.
APA
Kim, H., Lee, W.-S., Lee, K.-H., Bae, S. H., Kim, M. K., Joo, Y.-D., Zang, D. Y., Jo, J.-C., Lee, S. M., Lee, J.-H., Lee, J.-H., Kim, D.-Y., Ryoo, H.-M., Hyun, M. S., Kim, H. J., & CoOperative Study Group A for Hematology (COSAH). (2015). Efficacy of Helicobacter pylori eradication for the 1(st) line treatment of immune thrombocytopenia patients with moderate thrombocytopenia. Annals of Hematology, 94(5), 739–746. https://doi.org/10.1007/s00277-014-2268-9
Chicago
Kim, Hawk, Won-Sik Lee, Kyoo-Hyung Lee, Sung Hwa Bae, Min Kyoung Kim, Young-Don Joo, Dae Young Zang, et al. 2015. “Efficacy of Helicobacter Pylori Eradication for the 1(St) Line Treatment of Immune Thrombocytopenia Patients with Moderate Thrombocytopenia.” Annals of Hematology 94 (5): 739–46. doi:10.1007/s00277-014-2268-9.